Benign Prostatic Hyperplasia (BPH) Treatment Equipment Market to Grow with a CAGR of 4.40% through 2030

Rising Demand for Personalized Healthcare is expected to drive the Global Benign Prostatic Hyperplasia (BPH) Treatment Equipment Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Benign Prostatic Hyperplasia (BPH) Treatment Equipment- Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Benign Prostatic Hyperplasia (BPH) Treatment Equipment Market stood at USD 11.07 Billion in 2024 and is anticipated to grow with a CAGR of 4.40% through 2030. The growing demand for personalized healthcare is a key driver in the global Benign Prostatic Hyperplasia (BPH) treatment equipment market. As patients increasingly seek treatments that cater to their individual health conditions and preferences, there is a stronger emphasis on customized and targeted treatment options for BPH. Personalized healthcare enables more precise diagnosis and treatment, allowing healthcare providers to select the most suitable therapies based on factors such as the severity of BPH, the patient’s age, general health, and how they respond to previous treatments. In BPH treatment, the availability of advanced, minimally invasive options such as laser therapies, robotic systems, and High-Intensity Focused Ultrasound (HIFU) is enabling highly individualized care. These technologies offer effective, patient-specific treatments with fewer side effects and faster recovery times, making them increasingly popular among patients who seek tailored solutions. The rise of telemedicine and digital health technologies further enhances personalized care by giving patients more control over their treatment plans and providing doctors with detailed data to make more informed decisions. As the trend toward personalized healthcare continues to expand, it is expected to significantly drive growth in the BPH treatment equipment market.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Benign Prostatic Hyperplasia (BPH) Treatment Equipment Market”

Global Benign Prostatic Hyperplasia (BPH) Treatment Equipment Market is segmented into type, end user, regional distribution, and company.

Based on type, Laser-based Equipment emerged as the fastest growing segment in the global market for Benign Prostatic Hyperplasia (BPH) Treatment Equipment during the forecast period. This is primarily driven by the increasing demand for minimally invasive treatments that provide greater precision, quicker recovery, and reduced complications compared to traditional surgeries. Laser treatments, such as Holmium Laser Enucleation of the Prostate (HoLEP) and Photoselective Vaporization of the Prostate (PVP), effectively target and remove prostate tissue, resulting in improved patient outcomes. The segment's expansion is further supported by continuous advancements in laser technology, which enhance treatment efficacy, minimize side effects, and broaden the pool of patients who can benefit from these procedures. Moreover, laser treatments are gaining popularity in both hospital and outpatient settings due to their ability to address a wide range of BPH cases with minimal impact on patients' daily routines. The growing preference for these treatments, coupled with the increasing availability of advanced laser equipment, is strengthening the segment’s dominant position in the market. As healthcare providers continue to prioritize more efficient and patient-friendly solutions, the laser-based equipment segment is well-positioned to sustain its leadership in the BPH treatment market.

Based on Region, the Asia Pacific region is expected to be fastest growing region during the forecast period in global Benign Prostatic Hyperplasia (BPH) Treatment Equipment market. As the population in several Asia-Pacific countries ages, the prevalence of BPH is increasing, driving demand for effective treatment solutions. Governments in regions like China, India, and Japan are significantly boosting healthcare expenditures and enhancing infrastructure, improving access to advanced medical technologies. Growing awareness of BPH and its treatment options is leading to higher patient demand for minimally invasive therapies, such as laser and robotic treatments. The expansion of healthcare facilities and the rise of specialized urology centers are making BPH treatments more accessible, especially in emerging markets. The region is experiencing rapid advancements in medical technology, with a growing availability of innovative BPH treatment equipment, attracting investment from both local and global players. Additionally, Asia-Pacific countries offer cost-effective healthcare options, making advanced BPH treatments more affordable and appealing to a large patient base. Together, these factors are fueling significant growth in the BPH treatment equipment market, positioning the Asia-Pacific region as the fastest-growing globally.

Major companies operating in Global Benign Prostatic Hyperplasia (BPH) Treatment Equipment Market are:

• Urologix, LLC
• Olympus Corporation
• Boston Scientific Corporation
• Teleflex Incorporated
• Zenflow Inc.
• Sonablate Corporation
• Richard Wolf Gmbh
• Karl Storz SE
• Terumo Medical Corporation

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The global Benign Prostatic Hyperplasia (BPH) treatment equipment market is entering a transformative phase, driven by a shift in patient expectations and healthcare delivery models. As demand for minimally invasive and more comfortable treatments grows, BPH technologies are evolving to offer not only precision but also convenience, such as outpatient-based solutions and home-care devices. This growing emphasis on patient-centered care is reshaping the market, with a strong focus on reducing treatment-related disruption to daily life. Moreover, the rise of AI-driven diagnostics is paving the way for more tailored and efficient treatment approaches, opening new avenues for growth in the sector”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Benign Prostatic Hyperplasia (BPH) Treatment Equipment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Laser-based Equipment, Microwave-based Equipment, Radiofrequency-based Equipment, Other), By End user (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Benign Prostatic Hyperplasia (BPH) Treatment Equipment Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Benign Prostatic Hyperplasia (BPH) Treatment Equipment Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com